General
Preferred name
aminophenazone
Synonyms
AMINOPYRINE ()
Amidopyrine ()
AMINOPHENAZONE CYCLAMATE ()
NSC-4993 ()
Netsusarin ()
Aminofenazona ()
Febron ()
Itamidone ()
Amidopyrazoline ()
Mamallet a ()
Amidazophene ()
Dereuma ()
Brufaneuxol ()
4-dimethylaminoantipyrine ()
Cyclamate d'aminophenazone ()
Aminopyrine cyclamate ()
Ciclamato de aminofenazona ()
P&D ID
PD001715
CAS
58-15-1
144574-10-7
747-30-8
Tags
available
drug candidate
drug
First approval
1964
Drug Status
approved
withdrawn
investigational
Max Phase
4.0
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS
Aminophenazone exhibits analgesic, anti-inflammatory, and antipyretic properties.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
15
AdooQ Bioactive Compound Library
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
40
Properties
(calculated by RDKit )
Molecular Weight
231.14
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
2
cLogP
1.55
TPSA
30.17
Fraction CSP3
0.31
Chiral centers
0.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Indication
dermatitis herpetiformis (DH)
MOA
analgesic agent
ATC
N02BB03
N02BB53
N02BB73
Toxicity type
hematological
renal
Source data